Sanofi and GSK announced an unprecedented vaccine collaboration to fight COVID-19
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
Sinovac announced approval of human clinical trial for a vaccine candidate against COVID-19
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
Iceland provides picture of early spread of COVID-19 in population with cohesive public health response
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
Philips detailed plans to increase hospital ventilator production to 4,000 units/week by Q3 2020
On Apr. 14, 2020, Royal Philips updated its plans to double the production of its hospital ventilators by…
Philips joined forces with Flex and Jabil to speed the production of hospital ventilators
On Apr. 14, 2020, Philips announced that it had joined forces with manufacturing partners Flex and Jabil to…
New Philips Respironics E30 ventilator introduced to help free up ICU units in wake of COVID-19
On Apr. 14, 2020, Philips announced its initiative to quickly scale production of its new Philips Respironics E30…
NantKwest and ImmunityBio announced therapeutics and vaccines for combatting COVID-19
On Apr. 14, 2020, NantKwest and ImmunityBio announced discussions with the FDA for vaccines and therapeutics to combat…
The Jackson Laboratory to provide expanded Coronavirus testing for Maine hospitals
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced additional coronavirus…
CHF Solutions announced COVID-19 patients teated with Aquadex Therapy for fluid management when access to dialysis machines limited or not available
On Apr. 14, 2020, CHF Solutions announced that physicians on the frontlines of treating patients with COVID-19 have…
Meridian Bioscience offered SARS-CoV-2 antigens for COVID-19 antibody tests
On Apr. 14, 2020, Meridian Bioscience announced it had launched a series of recombinant antigens for high sensitivity…
Alberta Hope COVID-19 study tested early treatment option
On Apr. 13, 2020, a province wide trial was announced by Alberta Hope that will investigate the effectiveness…
NIH BRAIN Initiative tool helps researchers watch neural activity in 3D
On Apr. 13, 2020, an ultra-fast, 3D imaging technique called SCAPE microscopy, developed through the National Institutes of…
FDA approved first therapy for children with debilitating and disfiguring rare disease
On Apr. 13, 2020, the U.S. Food and Drug Administration (FDA) announced that given the increased demand for…
Large-scale analysis links glucose metabolism proteins in the brain to Alzheimerï¾’s disease biology
On Apr. 13, 2020, in the largest study to date of proteins related to Alzheimerï¾’s disease, a team…
RedHill Biopharma reported the first two patients treated with opaganib at a leading hospital in Israel
On Apr. 13, 2020, RedHill Biopharma announced the first two patients were treated with opaganib at a leading…
Pluristem treated first COVID-19 patient in US under FDA single patient expanded access program
On Apr. 13, 2020, Pluristem Therapeutics announced it has treated its first patient suffering from COVID-19 complications in…
Bausch Health initiated VIRAZOLEï¾® (Ribavirin for inhalation solution, USP) clinical study in patients with COVID-19
On Apr. 13, 2020, Bausch Health announced it has initiated a clinical trial program in Canada evaluating an…
Emory University developed diagnostic antibody blood test to determine antibody-responses to COVID-19
On Apr. 13, 2020, Emory University developed a sensitive and specific diagnostic antibody, also known as serological tests,…
Blackstone and Alnylam announced $2 billion strategic financing collaboration to accelerate advancement of RNAi therapeutics
On Apr. 13, 2020, Blackstone and Alnylam Pharma announced a broad strategic collaboration under which Blackstone will provide…
Mayo Clinic Laboratories launched serology testing in support of COVID-19 response
On Apr. 13, 2020, a new serology test from Mayo Clinic Laboratories that is used to identify the…
BD announced second FDA Emergency Use Authorization, CE Mark for new COVID-19 molecular diagnostic for global use
On Apr. 13, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
FDA authorized Athersys to initiate pvotal clinical trial evaluating MultiStemï¾® cell therapy in patients with COVID-19 induced ARDS
On Apr. 13, 2020, Athersys announced the FDA has authorized the Company to initiate a Phase 2/3 pivotal…
Aegis Sciences launched test for Coronavirus disease 2019 (COVID-19)
On Apr. 13, 2020, Aegis Sciences announced serving as a regional reference laboratory for COVID-19 testing being directed…
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
FDA approved first therapy for children with debilitating and disfiguring rare disease
On Apr. 10, 2020, the FDA approved AstraZeneca ‘s Koselugo (selumetinib) for treatment of pediatric patients, 2 years…
STERIS announced decontamination solution for rrespiratory masks
On Apr. 10, 2020, STERIS announced that the FDA issued an Emergency Use Authorization (EUA) for respirator decontamination….
IHME released updated COVID-19 predictions for deaths and hospital use in the European Economic Area
On Apr. 10, 2020, the Institute for Health Metrics and Evaluation (IHME) released updated COVID-19 predictions for deaths…
The US Dep of Veterans Affairs established the department’s first history office
On Apr. 10, 2020, the U.S. Department of Veterans Affairs (VA) established the VA History Office (VAHO) to…
Potential treatment for COVID-19 identified by BenevolentAI using artificial intelligence enters randomised clinical trial
On Apr. 10, 2020, BenevolentAI announced that baricitinib, which it had identified as a potential treatment for COVID-19,…
Data on 53 patients treated with investigational antiviral remdesivir through Compassionate Use Program published in NEJM
On Apr. 10, 2020, Gilead Sciences announced results from a cohort analysis of 53 patients hospitalized with severe…